宫颈癌肝转移的治疗研究进展OA北大核心CSTPCD
Research advances in the treatment of cervical cancer with liver metastasis
宫颈癌肝转移的发生率较低,常伴有其他部位的转移,预后差.针对宫颈癌肝转移的治疗需综合患者一般情况、病灶分布、初始治疗方式和预期生存目标等多种因素,制订个体化治疗方案,以达到延长患者生存时间、提高生存质量的目的.本文主要结合国内外研究探讨宫颈癌肝转移的临床特征、治疗现状以及预后情况.
Though liver metastasis of cervical cancer has a relatively low incidence rate,it is often accompanied by metastasis in other sites and thus has a poor prognosis.For the patients with liver metastasis of cervical cancer,it is necessary to formulate individualized treatment regimens based on various factors such as general status,lesion distribution,initial treatment modality,and life expectancy,so as to prolong the overall survival of patients and improve their quality of life.With reference to related studies in China and globally,this article reviews the clinical features,treatment,and prognosis of cervical cancer with liver metastasis.
谢尚丹;胡群超;诸海燕
同济大学附属妇产科医院妇科,上海 201204上海交通大学医学院附属同仁医院放疗科,上海 200000
宫颈肿瘤肿瘤转移肝治疗学
Uterine Cervical NeoplasmsNeoplasm MetastasisLiverTherapeutics
《临床肝胆病杂志》 2024 (007)
1307-1311 / 5
国家自然科学基金面上项目(82272778) General Project of National Natural Science Foundation of China(82272778)
评论